'Designer Baby' Gets Go-Ahead (UK)
By Deutsche Welle,
Deutsche Welle
| 09. 10. 2004
British legislation allows the use of embryos in stem cell therapy
A couple in Northern Ireland have been permitted under a recent law in Great Britain to pursue the process which would lead to the first "designer baby," an embryo which would provide cells that could help treat the family's seriously ill three-year-old son.
To look at Joshua Fletcher, one would not see any signs of the illness. But he has a rare and potentially fatal blood disease called Diamond Blackfan anemia. In two years time, Joshua will be too old for the stem-cell therapy which could keep him alive. So for his parents, news that the treatment has been authorized is like the revocation of a death sentence.
"The chances are 95 percent in favor that Joshua with be cured by this therapy," said his father, Joe Fletcher. "If we do not do this, he will soon die." This new chance of life will come from an artificially created embryo, designed to provide cells for Joshua which in turn will produce the healthy red blood cells that will keep him alive.
The possible treatment was made a reality in the...
Related Articles
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...
By Risa Cromer, The Conversation | 07.17.2026